This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Stocks Heat Up Despite Fed Tapering Concerns

NEW YORK (TheStreet) -- Futures for the broader market were gaining traction Monday as concerns about early Federal Reserve tapering of economic stimulus, following a spate of upbeat reports last week, was offset by optimism that the better data could translate into improved consumer confidence and increased spending.

Best Buy (BBY - Get Report) shares were adding on 1.84% to $43.19 after analysts at UBS upgraded the electronic retailer stock to "buy" from "neutral" and raised the price target to $49 from $35 on optimism about the company's earnings growth.

Express (EXPR - Get Report) shares were poised to open higher after Goldman Sachs analysts initiated coverage on the apparel retailer with a "buy" and a $28 price target, explaining that the company is poised for "outsized" earnings growth.

Futures for the S&P 500 were up 2.25 points, or 1.59 points above fair value, to 1,768.25. Futures for the Dow Jones Industrial Average were up 16 points, or 7.22 points above fair value, to 15,716. Futures for the Nasdaq were up 2 points, or 0.76 points above fair value, to 3,362.5.

Must Read: U.S. Stocks Soar on Robust Jobs Report

The S&P 500 rose 0.51% for the week last week and was up 24.15% year to date following uplifting reports on the U.S. labor market in October and third-quarter economic expansion. Furthermore, the European Central Bank cut its benchmark interest rate to stimulate growth.

Viropharma Pharmaceuticals (VPHM) shares were soaring more than 25% to $49.42 in premarket trading, and Shire SHPG was gaining 3.23% to $138.74 on their announcement that Shire is buying Viropharma Pharmaceuticals for $4.2 billion to bolster its portfolio of drugs treating rare diseases.

Grifols GRFS was adding 5.31% to $31.55 after the healthcare company said that it will buy the transfusion diagnostics unit of Novartis NVS for $1.675 billion.

All eyes will be on Fed Vice Chair Janet Yellen on Thursday as the nominee to replace Ben Bernanke as chair of the central bank will testify at a confirmation hearing before the U.S. Senate Committee on Banking, Housing, and Urban Affairs.

The FTSE 100 in London was rising 0.3% while the DAX in Germany was higher by 0.12%. The Hong Kong Hang Seng closed higher by 1.43% while the Nikkei 225 in Japan increased 1.3%.

December crude oil futures were down 29 cents to $94.31 a barrel and December gold futures were down $1 to $1,283.60 an ounce.

Bond markets were closed in observance of Veteran's Day. Overall U.S. stock trading volumes are expected to be light given the U.S. holiday.

--Written by Andrea Tse in New York

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BBY $31.50 -0.76%
EXPR $17.77 -0.22%
AAPL $94.19 -1.04%
FB $118.06 0.54%
GOOG $695.70 0.48%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs